Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-<i>co</i>-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform-Reference-Cited by-同舟云学术

Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-co-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform

Published:2017 Issue:2 Volume:40 Page:145-150
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Tanetsugu Yusuke¹,Tagami Tatsuaki¹,Terukina Takayuki¹,Ogawa Takaya²,Ohta Masato²,Ozeki Tetsuya¹

Affiliation:

1. Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University

2. Chemistry, Manufacturing & Control Research Laboratories, Meiji Seika Pharma Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/40/2/40_b16-00437/_pdf

Reference37 articles.

1. 1) Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N. Engl. J. Med., 342, 483–492 (2000).

2. 2) Dedania VS, Bakri SJ. Current perspectives on ranibizumab. Clin. Ophthalmol., 9, 533–542 (2015).

3. 3) Ba J, Peng RS, Xu D, Li YH, Shi H, Wang Q, Yu J. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis. Drug Design. Drug. Des. Devel. Ther., 9, 5397–5405 (2015).

4. 4) Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med., 355, 1419–1431 (2006).

5. 5) Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med., 355, 1432–1444 (2006).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball;Materials Today Bio;2024-08

2. Intravitreal therapeutic nanoparticles for age-related macular degeneration: Design principles, progress and opportunities;Advances in Colloid and Interface Science;2024-07

3. Developing a synergistic rate-retarding polymeric implant for controlling monoclonal antibody delivery in minimally invasive glaucoma surgery;International Journal of Biological Macromolecules;2024-06

4. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route;European Journal of Drug Metabolism and Pharmacokinetics;2024-04-18

5. Clinical Efficacy of Preoperative and Intraoperative Intravitreal Ranibizumab as Adjuvant Therapy of Ahmed Glaucoma Valve Implantation Combined with Vitrectomy in the Management of Neovascular Glaucoma with Diabetic Vitreous Hemorrhage;Journal of Personalized Medicine;2023-12-22